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Purpose: To evaluate the brain perfusion with MRI perfusion weighted imaging (PWI) before
and after ICA stenting in asymptomatic and symptomatic patients.
Materials and methods: PWI was performed 3–21 days before and 3 days after ICA stenting in
31 asymptomatic patients with ICA >70% stenosis – Group I, and in 14 symptomatic patients
with ICA >50% stenosis – Group II. PWI was evaluated qualitatively and quantitatively in 5
cerebral territories with: mean transit time (MTT), cerebral blood volume (CBV) and cerebral
blood ﬂow (CBF). Mean values of perfusion parameters were measured before and after
stenting DMTT, DCBV, DCBF were calculated as subtraction of after-treatment values from
those before treatment.
Results: In qualitative evaluation after ICA stenting perfusion was normalized in 21 patients
(80.8%) in Group I and in 8 patients (80%) in Group II.
In quantitative estimation MTT decreased signiﬁcantly after CAS on stented side vs. non-
stented side in all examined patients regardless of the group, p < 0.05. MTT decreased more
in Group II than in Group I in all territories ( p < 0.05) with the exception of temporal lobe. CBV
and CBF have shown insigniﬁcant differences.
Conclusions:
1. In MRI the most useful parameters to assess brain perfusion are MTT and DMTT:
regardless whether patients are asymptomatic or symptomatic.
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2. There were no signiﬁcant differences in CBV and CBF after stenting in both groups of
patients.
3. The positive effect of ICA stenting measured with decrease of MTT, CBV values and
increase of CBF value is more prominent in symptomatic patients.
# 2015 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
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Perfusion MRI can provide clinically useful information.
The best indicator of perfusion changes is MTT. Decrease
of MTT is more prominent in symptomatic patients.
1. Introduction
Internal carotid artery (ICA) stenosis can cause both acute
ischemic stroke and chronic brain ischemia.
Severe ICA stenosis discriminates cerebral perfusion in the
distal part of ICA vascularity – in vascularity territory of middle
cerebral artery and/or anterior cerebral artery.
The increase of cerebral perfusion disturbances depends
ﬁrst of all on the rate of the stenosis increase, the efﬁciency of
the circle of Willis, collateral circulation and also systemic
blood pressure. It depends less, and in the opinion of some
investigators does not depend at all, on carotid stenosis
severity [1–3].
The longer carotid artery atherosclerosis lasts the more
cerebral autoregulation is damaged, which in turn increases
the stroke risk [4].
The ﬁndings of a growing number of randomized clinical
studies show that ICA stenting improves cerebral perfusion.
The changes of cerebral perfusion are seen just after
intervention in symptomatic patients, while their inﬂuence
is less pronounced in asymptomatic patients [3,5–8].
The reports on perfusion with MRI are not numerous. It
especially refers to asymptomatic patients where the number
of patients examined is insufﬁcient to estimate credibly the
value of stenting in primary stroke prophylaxis and risk for
hyperperfusion syndrome, microhemorrhages or micro-
strokes producing the possibility of developing dementia in
the future.
An open question is whether asymptomatic patients
beneﬁt approximately just as symptomatic patients do, and
in which cases the risk of hyperperfusion syndrome exists
after stenting.
In most patients brain perfusion after ICA dilatation
increases by 20–40% over the baseline value. This increase
takes place in the ﬁrst few hours after intervention and is
mostly asymptomatic [9,10].
In some patients, most often 3–4 days after stenting, the
increase of perfusion evaluated with computer tomography
(CT) is above 100–200% of initial value found in the
contralateral hemisphere, which results in cerebral hyperemia
and clinical hyperperfusion syndrome [9].In most reports, hyperperfusion syndrome occurs in 0–3%
of cases [3,9]. It is a rare but dangerous complication of carotid
dilatation. This complication is considered as abnormal, worse
cerebral vascular bed reactivity as a result of prolonged
reduced perfusion on the stenosed artery side.
It is not more common in patients with severe ICA stenosis
or coexisting contralateral ICA stenosis [9,11,12]. Clinical
symptoms range from severe to almost none, through
headache, nausea, vomiting, blurred vision, epileptic seizures,
focal neurological symptoms to acute cerebral edema, intra-
cranial hemorrhage. But also an opposite phenomenon is
seen: in spite of clinical symptoms of hyperperfusion
syndrome increased cerebral perfusion does not appear [9].
PWI and DWI with MRI help detect perfusion disturbances,
ischemic changes at their earliest phase without changes in
cerebral tissue, give an insight into stroke dynamics in vivo [13].
There are two commonly used methods to measure MRI
perfusion [14–17]. The more popular is dynamic susceptibility
contrast imaging (DCS–MRI). It uses rapid measurements of
MRI signal change in the brain during the ﬁrst pass of a
paramagnetic contrast bolus injected intravenously. Either T1,
T2 or T2* weighted sequences can be used. The deconvolution
of an arterial input function is necessary to obtain the tissue
response function and to produce maps of perfusion param-
eters: MTT, CBV and CBF. T0 (time to arrival) and TTP (time to
peak) could be estimated to show the local variations of
contrast arrival time. Usage of a standard dose 0.1 mmol/kg
b.w. of high relaxivity contrast agent or a double dose of
conventional contrast agent improve the signal to noise ratio
[15,18] resulting in high quality of obtained images.
The other technique is arterial spin labeling ASL. It is an
endogenous tracer method in which the magnetically labeled
protons in inﬂowing blood exchange with tissue protons
producing the change of signal. The image of cerebral blood
ﬂow can be obtain by measuring signal changes between
labeled and baseline unlabeled images.
The study of perfusion parameters before and after ICA
stenting can bring the knowledge about pathophysiological
factors of stroke, cerebral autoregulation disturbances in
asymptomatic and symptomatic patients with ICA stenosis,
help identify patients at risk for hyperperfusion syndrome
[3,11]. The information from DWI, PWI imaging can be used in
choosing treatment methods and evaluating complications
[19–21].
DWI, PWI and their correlation with neurological state
seem to allow physicians to detect a patient's proﬁle, risk
factors, characteristics predicting the onset of such complica-
tions as hyperperfusion syndrome, vegetative disturbances,
and can improve patients' selection who will beneﬁt from
revascularization [22].
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1. To assess qualitatively perfusion in asymptomatic and
symptomatic patients with ICA stenosis before and after
stenting in early phase.
2. To assess quantitatively perfusion before and in early phase
after stenting with PWI (MTT, CBV, CBF) in homologous
brain areas on the stented and non-stented sides in
asymptomatic and symptomatic patients.
3. Materials and methods
The study was carried out with the approval of the
Institutional Ethics Committee and a written informed
consent was obtained from each patient.
3.1. Subjects
Group I included 31 patients (8 females, 23 males) with
asymptomatic ICA stenosis; aged 52–79 years, mean 68.4 years.
Perfusion qualitative and quantitative evaluations were
performed in all participants.
Group II included 14 patients (5 females, 9 males) with
symptomatic ICA stenosis; aged 50–77 years, mean 63.4 years.
PWI was assessed qualitatively in 14 patients, quantita-
tively in 12 patients.
Inclusion criteria were:
 contraindications to ICA endarterectomy;
 lack of patient's consent for surgery;
 informed patient's consent for ICA stenting;
 lack of contraindications to MRI;
 Group I – asymptomatic, unilateral ICA stenosis 70–99%;
irrelevant stenosis <50% of contralateral ICA;
 Group II – symptomatic ICA stenosis >50% responsible for
cerebral vascular incidents;
TIA, previous strokes – within 180 days before the study;
stenosis of contralateral ICA even to 90%.
Exclusion criteria were:
 ICA occlusion;
 absolute contraindication to dual antiplatelet therapy
(gastrointestinal bleeding, acute hemorrhagic stroke, acet-
ylsalicylic acid allergy);
 symptomatic >50% ICA tenosis + severe heart insufﬁciency
– NYHA IV class;
 left ventricular dysfunction – ejection fraction <30%;
 recent myocardial infarction – up to 30 days from attack;
 severe lung disease;
 kidney insufﬁciency – GFR < 50 ml/min  1.72 m2.
All interventions were performed with neuroprotection.
3.2. Magnetic resonance imaging
MRI scans were obtained 3–21 days before and 3 days after ICA
stenting.Imaging was performed with a 1.5 T scanner (Magnetom
Avanto; Siemens) using of a standard quadrature head coil.
The study included morphological evaluation, diffusion-
weighted imaging (DWI) and cerebral perfusion.
The scanning protocols included: axial T1-weighted images
(spin-echo; TR = 470 ms, TE = 11 ms). T2-weighted images
(spin-echo TR = 4750 ms, TE = 105 ms), ﬂuid-attenuated inver-
sion recovery images (T2 TIRM TR:9000 ms, TE = 89 ms,
TI = 2500 ms), diffusion-weighted images using single-shot
echo-planar imaging sequence (TR = 3200 ms, TE = 101 ms, b-
values = 0, 500, 1000 and 1500 s/mm2), susceptibility weighted
images (3D GR,TR = 49 ms, TE = 40 ms).
PWI data were acquired using a T2*-weighted echo-planar
dynamic volume imaging sequence (dynamic susceptibility
contrast imaging) (TR = 1580 ms, TE = 41 ms, 5 mm slice/
1.5 mm intersection gap, 50 series of 19 slices, total acquisition
time 1.24 min) after intravenous injection of standard dose
0.1 ml/kg/b.w. of a high relaxivity paramagnetic contrast agent
gadobenate dimeglumine (Gd-BOPTA, MultiHance Bracco) at
5 ml/s followed by a 20 ml ﬂush of saline with the use of an
automatic injector [18].
Qualitative evaluation was made on the basis of perfusion
maps created by software provided by the MR scanner
manufacturer.
Quantitative evaluation was performed in Nordic ICE v
2.3.12 software with perfusion module of the Nordic Neurolab
company. For this analysis the maps were created separately
for each tested parameter: MTT, CBV, CBF.
MTT, mean transit time in seconds; CBV, cerebral blood
volume in ml/100 g tissue; CBF, cerebral blood ﬂow in ml/
100 g tissue/min.
3.3. Image analysis
Changes in 5 brain areas in the vascular territory of ICA [22]
were compared for MTT, CBV, CBF; 1 and 4 – frontal lobe (basis
and above fornix), 2 – temporal lobe, 3 – basal ganglia (head of
caudate nucleus), 5 – parietal lobe.
Qualitative evaluation was made on the basis of color-
coded perfusion maps created by software provided by the MR
scanner manufacturer. The rainbow scale of colors was used –
from red color for the highest value to violet for lowest – to
compare the maps of the same parameter created for every
patient. The assessment was based on the changes of colors
and their intensity in the comparative regions of the brain.
3.4. Quantitative evaluation
The round shape regions of interest (ROI) area were: region no
1, 2, 4 and 5 – 452.03 mm2, region no 3 – 219.56 mm2. The
location of particular ROI was drowned manually avoiding
infarct lesions and sylvian ﬁssure in similar location of the
brain hemisphere in every patient and automatically copied
parallel to the midline of the brain on the both hemispheres
(Fig. 1). Measurements were made before and after stenting
separately for each hemisphere. The mean values of perfusion
parameters and their changes after treatment (DMTT, DCBV
and DCBF) calculated as the subtraction of after-treatment
from before-treatment values were speciﬁed for all analyzed
areas before and after ICA stenting. The results of perfusion
Fig. 1 – MRI perfusion maps of MTT (upper) and CBV (lower)
with ROI placement.
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Groups I and II. The values for the stented and non-stented
side were compared in all patients and in Groups I and II
separately.
Hyperperfusion syndrome criteria were: pulsating head-
ache, nausea, vomiting, consciousness disturbance, epileptic
seizure, focal neurological symptoms.
3.5. Statistical analysis
Analysis of variance ANOVA in repeated measurements were
used to test for differences in categorical variables.
The 2-tailed probability p value <0.05 was considered
statistically signiﬁcant.
4. Results
4.1. Qualitative perfusion evaluation in Group I
Initial PWI study was normal in 5 patients (16.1%), impaired
perfusion with varying degrees of severity in narrowed artery
territory was present in 26 patients (83.9%).
Perfusion was normalized after stenting in 21(80.8%) out of
26 patients. The total of 25 PWI studies was normal (80.6%).
Hyperperfusion was in 2 patients (6.6%): in one case initial PWI
was normal, the other presented impaired perfusion in initial
examination.
In 4 (13%) both PWI studies revealed the same perfusion
deﬁcit.
In 4 (13%) cases the symptoms of clinical hyperperfusion
syndrome were observed, mostly they were severe headaches:
in 2 cases – impaired perfusion in initial PWI, normalization incontrol PWI, 1 case – both PWI studies were normal, 1 case –
impaired initial PWI, hyperperfusion in control PWI.
In 4 cases (13%), during or several hours after intervention,
TIA appeared with symptoms from the territory of expanded
ICA. In 3 cases perfusion normalization was seen in control
study, in 1 case both PWI studies were normal.
4.2. Qualitative perfusion evaluation in Group II
In 4 (28.6%) patients, initial and after intervention PWI were
normal. Out of 10 cases, impaired initial perfusion improved
after stenting in 8 patients (80%).
After ICA treatment in 2 cases of impaired initial perfusion
there was no improvement in 1 patient, in the other the
perfusion assessment was not possible because of hematoma.
In no case did perfusion in PWI increase clearly, while in 2
patients (14.3%) clinical hyperperfusion syndrome occurred; in
one patient severe neurological symptoms – aphasia and right
hemiparesis; in the other, hematoma in the area of enlarged
artery vascularity in the second day after stenting.
There was one TIA case in this group.
4.3. Quantitative perfusion analysis in both groups of
patients
Analysis of perfusion parameters was carried out before and
after ICA stenting in all of the patients independently of the
side: stented and non-stented, The analysis of variance was
made for the whole group of patients and independently in
Group I and Group II and compared between groups.
Before stenting the initial values of MTT were higher in
Group II in all assessed areas in comparison with Group I. Also
the values of MTT in the stented hemisphere were higher than
in contralateral hemisphere.
After intervention statistically signiﬁcant decrease of MTT
value (negative DMTT) was observed in symptomatic group in
regions 1, 3, 4 and 5 comparing to asymptomatic group.
In region 2 – temporal lobe the change of the value was
insigniﬁcant.
Statistically signiﬁcant decrease of MTT value (negative
DMTT) was also observed on stented side vs. non-stented side
in all areas regardless of patient group.
The results of DMTT are shown in Table 1 and Figs. 2 and 3.
The results of DMTT in multivariable analysis are presented
in Fig. 4.
In multivariable analysis between groups of patients
despite visible differences of DMTT values in Group II
(symptomatic patients) in the stented hemisphere vs. non-
stented one and in comparison with Group I (asymptomatic
patients) the analyzed values were not statistically signiﬁcant
in all assessed areas.
The multivariable analysis of results of DCBV and DCBF are
shown in Figs. 5 and 6.
No statistically signiﬁcant changes of DCBV were seen. The
values of CBV decreased or remained unchanged, with the
exception of an apparent decline in the DCBV values in Group II
in the affected hemisphere especially in the temporal lobe.
The values of DCBF were insigniﬁcant; DCBF increased or
remained unchanged, but DCBF values increased in Group II on
the stented site, most visibly in the temporal lobe.
Table 1 – DMTT in asymptomatic and symptomatic groups in stented and non-stented hemispheres in evaluated regions.
DMTT Asymptomatic Symptomatic p Non-stented side Stented side p
DMTT 1 0.52 1.35 0.0194 0.57 1.26 0.0370
DMTT 2 0.45 1.05 0.0594 0.13 1.36 0.0002
DMTT 3 0.29 0.99 0.0081 0.29 1.01 0.0065
DMTT 4 0.26 1.24 0.0011 0.38 1.13 0.0116
DMTT 5 0.21 1.33 0.0011 0.18 1.35 0.0006
DMTT – in seconds, 1 – frontal lobe basis, 2 – temporal lobe, 3 – basal ganglia, 4 – frontal lobe above fornix, 5 – parietal lobe, p – p value.
Fig. 2 – DMTT in seconds in evaluated brain areas in both
groups of patients.
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syndrome and TIA during ICA treatment.
Hyperperfusion syndrome occurred in 6 patients; 4 in
Group I and 2 in Group II. In these patients no statistically
signiﬁcant differences were seen in all PWI parameters before
and after stenting.
After ICA treatment, the decrease of mean MTT value
(negative DMTT) by 0.1–0.9 s was observed in all patients on the
stented side.
CBV mean value increased (positive DCBV) slightly in
frontal lobe by 0.31 ml/100 g, in the remaining areas decreased
(negative DCBV) by 0.65–2.8 ml/100 g.
CBF mean value increased (positive DCBF) only in basal
ganglia on the stented side by 9.15 ml/100 g/min, in the
remaining areas it decreased (negative DCBF) by 2.4–7.7 ml/
100 g/min.Fig. 3 – DMTT in seconds in evaluated brain areas in stented
and non-stented hemisphere.In 4 patients in Group I and one patient in Group II, TIA
occurred during stenting. In none of these patients there were
any statistically signiﬁcant differences in PWI parameters. On
the stented side MTT decreased (negative DMTT) by 0.5–1.31 s,
CBV decreased (negative DCBV) by 0.7–3 ml/100 g, CBF in-
creased (positive DCBF) in frontal lobe basis by 5.7 ml/100 g/
min and in parietal lobe by 2.9 ml/100 g/min and decreased in
the other regions by 3.1–16.9 ml/100 g/min.
In Group I in DWI new small, ischemic lesions were found
in 11 (35.5%) cases, in Group II only in 2 (14.3%) patients.
5. Discussion
Despite a long history of treating stenosed ICA, the literature
assessing the effectiveness of this treatment method on the
basis of perfusion evaluation is quite poor.
The available literature evaluates quantitatively brain
perfusion before and after ICA stenting mostly with perfusion
study by computed tomography (PCT) and in symptomatic
patients.
There are few reports evaluating the usefulness of MRI in a
brain perfusion study, and they are qualitative assessments
[23].
Due to the relative variable dependent on the stability of the
magnetic ﬁeld of the apparatus, inﬂuence of protocol of
examination and the type of contrast agent, the accuracy of
measurement of perfusion parameters should be treated as
relative.
Because of that fact only relative comparison of PWI results
from different scanners can be possible (the absolute standard
does not exist) and the relative comparison with the standards
drawn up on the basis of studies PCT.
We chose the method of quantitative PWI assessment,
which takes these limitations into account.
The changes of measured values were calculated as the
results of the subtraction of after-treatment value from
those before treatment and presented as DMTT, DCBV and
DCBF and the multivariable model was used in statistical
analysis.
Before stenting in symptomatic patients, MTT values were
higher, while CBF values visibly lower in the affected
hemisphere in relation to the contralateral side. It suggests
that the decrease in cerebrovascular reactivity was the result
of the fact that the cerebral vascular bed was no longer able to
dilate [24].
After treatment MTT shortened statistically signiﬁcant
(negative DMTT) on the stented side in relation to the
contralateral side independently of the studied group in all
assessed areas.
Fig. 4 – Multivariable analysis DMTT value in seconds in evaluated brain areas depending on non-stented and stented site
and group of patients. The decreased of MTT are shown as negative DMTT.
Fig. 5 – Multivariable analysis of DCBV value in ml/100 g in evaluated brain areas depending on non-stented and stented side
and group of patients. The decrease of CBV is shown as negative DCBV.
Fig. 6 – Multivariable analysis of DCBF value in ml/100 g/min in evaluated brain regions depending on non-stented and
stented side and group of patients. The increase of CBF is shown as positive DCBF.
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higher in symptomatic group vs. asymptomatic group in all
assessed areas except temporal lobe. This fact can be
explained by measurement error or the possible impact of
posterior cerebral artery supply of this region [22].
Comparing the values of DMTT on stented and non-stented
sides in symptomatic patients vs. asymptomatic patients no
statistically signiﬁcant changes of DMTT were found but DMTT
values were visibly higher in symptomatic patient on both
sides. The lack of statistical signiﬁcance may be due to the
small numbers of symptomatic patients.
In asymptomatic patients in parietal lobe on non-stented
side DMTT slightly increase, but on stented side it slightly
decrease. This after-treatment phenomenon is probably due to
hemodynamic improvement on stented side so the higher
MTT values on non-stented side were noted.
DCBV and DCBF values changed insigniﬁcantly in both
groups of patients. DCBV generally increased or remained
unchanged on stented side and decreased or remained
unchanged on non-stented side regardless of the group of
patients.
But clear decrease of DCBV in symptomatic group
was observed on the stented side, especially in temporal
lobe, which was accompanied by a marked increase in the
value of DCBF. This shows a positive impact of stenting on
cerebral hemodynamics in symptomatic patients. This
phenomenon was not as much observed in asymptomatic
group.
The results of our work are in many points, similar to the
reports of other authors [25–28].
After treatment all reports observed reduced MTT, most
researchers also pointed out the perfusion, measured by CBF
indicator, increase.
Trojanowska et al. [25] in 50 subjects out of 74 with
unilateral, symptomatic ICA stenosis (in 24 patients the other
artery was occluded) found in their PCT study carried out in the
third day after stenting an improvement in PWI parameters in
70% subjects, but the perfusion deﬁcit symptoms remained in
30% patients. MTT shortened and CBF increased, CBV did not
change after stenting. Before and after treatment both CBF and
CBV were lower in the stented hemisphere vs. the non-stented
one.
Gaudiello et al. [26] in 20 subjects, both symptomatic (15
cases) and asymptomatic (5 cases) found in PCT in the seventh
day after treatment of stenosed ICA signiﬁcant MTT shorten-
ing with simultaneous CBF increase on the stented side. Yet
the values of these indicators did not change signiﬁcantly in
the non-stented side. Absolute values of these parameters
were applied in the assessment.
Duan et al. [27] in 20 patients with symptomatic ICA
stenosis found in PCT carried out in the seventh day after
ICA treatment a signiﬁcant rCBF increase and rMTT
shortening in the vascular area of dilated ICA, but not in
basal ganglia.
There were no signiﬁcant changes in rCBV. Relative values
of perfusion were calculated by comparing absolute values in
symptomatic hemisphere to absolute values in asymptomatic
hemisphere.
Szarmach et al. obtained slightly different results [28]. In
assessing CT perfusion (absolute values) in 20 symptomaticsubjects with ICA stenosis they found in the study made 4–8
weeks after stenting ICA, MTT shortening on the treated side
without statistically signiﬁcant changes in CBV and CBF
values.
Mercel and all [29] comparing relative values (obtained by
comparing treated to untreated hemisphere) of perfusion
parameters in CT in 31 symptomatic and 14 asymptomatic
patients found after treatment a statistically signiﬁcant
change in MTT values between the treated and untreated
hemispheres (dMTT) only in symptomatic patients. In asymp-
tomatic this parameter did not change signiﬁcantly. Similar to
our results the dMTT was also higher in symptomatic patients,
but this difference was not signiﬁcant. They thought this
ﬁnding conﬁrmed the presence of differences in cerebral
hemodynamic between symptomatic and asymptomatic
patients. The ratio of CBV (rCBV) between the above-
mentioned hemispheres decreased and the ratio of CBF (rCBF)
increased.
In 14 asymptomatic patients they found only a signiﬁcant
rCBF increase after treatment. By comparing both groups
before stenting they observed signiﬁcantly lower rCBF values
in symptomatic patients. The drop in rCBV value after
intervention was signiﬁcantly lower in symptomatic subjects
vs. asymptomatic patients.
In our study this trend to more prominent decrease of CBV
and increase of CBF (lower values before treatment) after
treatment in symptomatic subjects was also observed show-
ing the differences in hemodynamic status between symp-
tomatic and asymptomatic patients.
Waaijer et al. [30] in patients with unilateral symptom-
atic carotid stenosis reported that MTT was the most useful
and reproducible parameter of perfusion. Quantitative
analysis of CBV and CBF values should be interpreted with
caution.
Piñero et al. [31] examining perfusion by DSC–MRI in 33
patients with severe ICA stenosis found before and on the ﬁrst
day after treatment statistically signiﬁcant increase of TTP
(time to peak) and T0 arrival time (T0) on the stenosed side vs.
contralateral side. The values of this parameters normalized
30 days after treatment.
Tavares et al. [32] in 21 patients with severe ICA (≥60%)
stenosis in MRI contrast perfusion made 12 h before and 72 h
after ICA stenting found the hemodynamic improvement
on the stented side described by statistically signiﬁcant
decrease of MTT ( p < 0.001) and signiﬁcant decrease of TTP
( p = 0.019). This results were obtained for the relative values
of perfusion calculated by comparing absolute values in
symptomatic hemisphere to absolute values in asymptom-
atic one.
We did not analyze the TTP and T0 value in our study. TTP
and T0 concern to the vascular phase of perfusion, while we
chose to analyze the tissue response parameters of perfusion
as the main object of our study. The values of TTP and T0
mainly depend on the blood supply and contrast dispersion
and in to some degree on MTT value and are a good indicators
of the severity of ICA stenosis. They do not describe
independently the real conditions of hemodynamic status of
brain tissue, which could be inﬂuenced by the contralateral
blood supply via circle of Willis and auto regulatory processes
[33].
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of contralateral blood supply were pointed out in works
describing the lack of straight dependence of the severity of
ICA stenosis on brain perfusion status [1–3].
Chang et al. [34] in DCS–MRI analyzed the change of CBF in
patients with severe (≥70%) ICA stenosis before and on days
3–5 after stenting in comparing to cerebral vasoreactivity (CVR)
representing the reserve capacity of cerebral perfusion. CVR
was evaluated before treatment by fMRI using BOLD (blood
oxygen level-dependent) technique. They found the statisti-
cally signiﬁcant higher increase of CBF on stented side in short
time after treatment in patients with impaired CVR. Im-
pairment of CVR is reported as an independent risk factor for
ischemic stroke and TIA in patients with critical carotid
stenosis or occlusion and slightly higher risk for hyperperfu-
sion syndrome after stenting. We observed a similar phenom-
enon of higher CBF increase in symptomatic patients after
stenting, but not in the whole group with hyperperfusion
symptoms.
This ﬁnding could be an indicator of more severe
impairment of brain autoregulation in symptomatic patients.
This study indicate how important is the proper qualiﬁcation
to the ICA stenting to prevent the patients from complications
after procedure.
In our group with hyperperfusion syndrome, the perfusion
values obtained met the criteria for increased brain perfusion
[35]. We did not notice, (cited in the literature) the appearance
of risk factor of hyperperfusion syndrome as increased MTT
before treatment by at least 3 s in relation to the contralateral
side [36].
In patients with TIA during treatment the most important
is visible shortening of MTT accompanied by a drop of CBV
value and a slight increase or decrease (depending of analyzed
region) in CBF at the same time. Clinical symptoms, however,
can result from the kind of neuroprotection used during the
endovascular procedure itself or from microembolisms.
The results tend toward the following conclusions:
1. In MRI the most useful parameters to assess brain perfusion
are MTT and DMTT: regardless whether patients are
asymptomatic or symptomatic.
2. There were no statistically signiﬁcant differences in CBV
and CBF after stenting in both groups of patients possibly
due to the efﬁciency of cerebral autoregulation but this
phenomenon was more pronounced in asymptomatic
patients.
3. The positive effect of ICA stenting measured with decrease
of MTT, CBV values and increase of CBF value is more
prominent in symptomatic patients.
4. Slightly decreased MTT, decreased CBV and increased CBF
in basal ganglia in patients with hyperperfusion syndrome
can attest to the effectiveness of ICA stenting and TIA can be
an indicator of procedure complication itself.
Conﬂict of interest
We wish to conﬁrm that there are no known conﬂicts of
interest associated with this study.Acknowledgement and ﬁnancial support
We wish to conﬁrm that there has been no ﬁnancial support
for this work.
Ethics
The work described in this article has been carried out in
accordance with The Code of Ethics of the World Medical
Association (Declaration of Helsinki) for experiments involv-
ing humans; Uniform Requirements for manuscripts submit-
ted to Biomedical journals.
r e f e r e n c e s
[1] Wojczal J. TCD and perfusion CT in patients before and after
carotid artery stenting. Polski Przegląd Neurologiczny
2008;4(Suppl A):64.
[2] Reiche W, Schäfer R, Müller M, Hermes M. Cerebral
perfusion reserve and collateral circulation in patients with
internal carotid stenosis. Radiologe 1997;37(11):891–8.
[3] Ko NU, Achrol AS, Chopra M, Saha M, Gupta D, Smith WS,
et al. Cerebral blood ﬂow changes after endovascular
treatment of cerebrovascular stenoses. AJNR Am J
Neuroradiol 2005;26:538–42.
[4] Reinhard M, Roth M, Müller T, Czosnyka M, Timmer J,
Hetzel A. Cerebral autoregulation in carotid artery occlusive
disease assessed from spontaneous blood pressure
ﬂuctuations by the correlation coefﬁcient index. Stroke
2003;34(9):2138–44.
[5] Reinhard M, Roth M, Müller T, Guschlbauer B, Timmer J,
Czosnyka M, Hetzel A. Effect of carotid endarterectomy or
stenting on impairment of dynamic cerebral
autoregulation. Stroke 2004;35(6):1381–7.
[6] Wilkinson ID, Grifﬁths PD, Hoggard N, Cleveland TJ, Gaines
PA, Macdonald S, et al. Short-term changes in cerebral
microhemodynamics after carotid stenting. AJNR Am J
Neuroradiol 2003;24(8):1501–7.
[7] Tang SC, Huang YW, Shieh JS, Huang SJ, Yip PK, Jeng JS.
Dynamic cerebral autoregulation in carotid stenosis
before and after carotid stenting. J Vasc Surg 2008;48(1):
88–92.
[8] Sfyroeras G, Arsos G, Karkos CD, Liasidis C, Spyridis C,
Boundas D, et al. Interhemispheric asymmetry in brain
perfusion before and after carotid stenting: a 99 m Tc-
HMPAO SPECT study. J Endovasc Ther 2006;13(6):729–37.
[9] Jędrzejewska J, Kobayashi A. Hyperperfusion syndrome.
Terapia 2007;15(2):26–31.
[10] Van Laar PJ, Hendrikse J, Mali WP, Moll FL, van der Worp HB,
van Osch MJ, et al. Altered ﬂow territories after carotid
stenting and carotid endarterectomy. J Vasc Surg 2007;45
(6):1151–61.
[11] Fukuda T, Ogasawara K, Kobayashi N, Komoribayashi N,
Endo H, Inoue T, et al. Prediction of cerebral hyperperfusion
after carotid endarterectomy using cerebral blood volume
measured by perfusion-weighted MR imaging compared
with single-photon emission CT. AJNR Am J Neuroradiol
2007;28(4):737–42.
[12] Ascher E, Markevich N, Schutzer RW, Kallakuri S, Jacob T,
Hingorani AP. Cerebral hyperperfusion syndrome after
carotid endarterctomy; predictive factors and
hemodynamic changes. J Vasc Surg 2003;37(4):769–77.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 9 ( 2 0 1 5 ) 4 1 2 – 4 2 0420[13] Rosenberger R, Wojtek P, Konopka M, Pieniążek P, Bogusz I,
Sąsiadek M. Clinical applications of perfusion computed
tomography, diffusion-weighted magnetic resonance and
perfusion – weighted magnetic resonance imaging in
detection of early lesions in ischemic stroke. Udar Mózgu
2004;6(2):71–8.
[14] Petrella JR, Provenzale JM. MR perfusion imaging of the
brain: techniques and applications. AJR Am J Roentgenol
2000;175:207–19.
[15] Keston P, Murray AD, Jackson A. Cerebral perfusion imaging
using contrast-enhanced MRI. Clin Radiol 2003;58(7):505–13.
[16] Polloc JM, Tan H, Kraft RA, Whitlow CT, Burdette JH,
Maldjian JA. Arterial spin labeled MRI perfusion imaging:
clinical applications. Magn Reson Imaging Clin N Am
2009;17(2):315–38.
[17] Essig M, Shiroishi MS, Nguyen TB, Saake M, Provenzale JM,
Enterline D, et al. Perfusion MRI: the ﬁve most frequently
asked technical questions. AJR Am J Roentgenol 2013;200
(1):24–34.
[18] Cotton F, Hermier M. The advantage of high relaxivity
contras agents in brain perfusion. Eur Radiol 2006;16(Suppl
7):M16–26.
[19] Restrepo L, Wityk RJ, Grega MA, Borowicz Jr L, Barker PB,
Jacobs MA, et al. Diffusion- and perfusion-weighted
magnetic resonance imaging of the brain before and after
coronary artery bypass grafting surgery. Stroke
2002;33:2909–15.
[20] Skjelland M, Krohg-Sørensen K, Tennøe B, Bakke SJ, Brucher
R, Russell D. Cerebral microemboli and brain injury during
carotid artery endarterectomy and stenting. Stroke 2009;40
(1):230–4.
[21] Bonati LH, Jongen LM, Haller S, Flach HZ, Dobson J,
Nederkoorn PJ, et al. ICSS-MRI Study Group. New ischaemic
brain lesions on MRI after stenting or endarterectomy for
symptomatic carotid stenosis: a substudy of the
International Carotid Stenting Study (ICSS). Lancet Neurol
2010;9(4):353–62.
[22] Gauvrit JY, Delmaire C, Henon H, Debette S, Al Koussa M,
Leys D, et al. Diffusion/perfusion-weighted magnetic
resonance imaging after carotid angioplasty and stenting. J
Neurol 2004;251(9):1060–7.
[23] Van der Zwan A, Hillen B. Review of the variability of the
territories of the major cerebral arteries. Stroke
1991;22:1078–84.
[24] Soinne L, Helenius J, Tatlisumak T, Saimanen E, Salonen O,
Lindsberg PJ, Kaste M. Cerebral hemodynamics in
asymptomatic and symptomatic patients with high-grade
carotid stenosis undergoing carotid endarterectomy. Stroke
2003;34(7):1655–61.
[25] Trojanowska A, Drop A, Jargiełło T, Wojczal J, Szczerbo-
Trojanowska M. Changes in cerebral hemodynamice aftercarotid stenting: evaluation with CT perfusion studies. J
Neuroradiol 2006;33:169–74.
[26] Gaudiello F, Colangelo V, Bolacchi F, Melis M, Gandini R,
Garaci FG, et al. Sixty-four-section CT cerebral perfusion
evaluation in patients with carotid artery stenosis before
and after stenting with a cerebral protection device. AJNR
Am J Neuroradiol 2008;29:919–23.
[27] Duan Y, Li G, Yang Y, Li J, Huang H, Wang H, et al. Changes
in cerebral hemodynamics after carotid stenting of
symptomatic carotid artery. Eur J Radiol 2012;81(4):744–8.
[28] Szarmach A, Halena G, Buczny J, Studniarek M, Markiet K,
Szurowska E, et al. Evaluation of changes in the parameters
of brain tissue perfusion in multi-slice computed
tomography in patients after carotid artery stenting. Pol J
Radiol 2011;76(3):7–15.
[29] Merckel LG, Van der Heijden J, Jongen LM, van Es HW,
Prokop M, Waaijer A. Effect of stenting on cerebral CT
perfusion in symptomatic and asymptomatic patients with
carotid artery stenosis. AJNR Am J Neuroradiol 2012;33
(2):280–5.
[30] Waaijer A, van der Schaaf IC, Velthuis BK, Quius M, van
Osch MJ, Vonken EP, et al. Reproducibility of quantitative
CT brain perfusion measurements in patients with
symptomatic unilateral carotid artery stenosis. Am J
Neuroradiol 2007;28(5):927–32.
[31] Piñero P, Gonzáles A, Moniche F, Martinez E, Cayuela A,
Gonzáles-Marcos J-R, et al. Progressive changes in cerebral
perfusion after carotid stenting: a dynamic susceptibility
contrast perfusion weighted imaging study. J
Neurointervent Surg 2014;6:527–32.
[32] Tavares A, Caldas JG, Castro CC, Puglia Jr P, Frudit ME,
Barbosa LA. Changes in perfusion-weighted magnetic
resonance imaging after carotid angioplasty with stent.
Interv Neuroradiol 2010;16(2):161–9.
[33] Calamante F, Christensen S, Desmond PM, Østergaard L,
Davis SM, Connelly A. The physiological signiﬁcance of the
time-to-maximum (Tmax) parameter in perfusion MRI.
Stroke 2010;41:1169–74.
[34] Chang TY, Liu HL, Lee TH, Kuan WC, Chang CH, Wu HC,
et al. Change in cerebral perfusion after carotid angioplasty
with stenting is related to cerebral vasoreactivity: a study
using dynamic susceptibility-weighted contras enhanced
MR imaging and functional MR imaging with breath-hold
paradigm. AJNR Am J Neuroradiol 2009;30:1330–6.
[35] Moulakakis KG, Mylonas SN, Sfyroeras GS, Andrikopoulos
V. Hyperperfusion syndrome after carotid
revascularization. J Vasc Surg 2009;49(4):1060–8.
[36] Tseng YC, Hsu HL, Lee TH, Hsieh IC, Chen CJ. Prediction of
cerebral hyperperfusion syndrome after carotid stenting: a
cerebral perfusion computed tomography study. J Comput
Assist Tomogr 2009;33(4):540–5.
